Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.
Body mass index influences post-infusion levels of Infliximab and is associated with prospective response loss to the drug in a cohort of Inflammatory bowel disease patients under maintenance therapy with Infliximab.